Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Urovant Sciences GmbH
🇨ðŸ‡
Switzerland
Country
🇨ðŸ‡
Switzerland
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity
Phase 1
Terminated
Conditions
Overactive Bladder
Interventions
Drug: hMaxi-K
Other: Placebo
Subscribe
First Posted Date
2007-07-02
Last Posted Date
2019-06-28
Lead Sponsor
Urovant Sciences GmbH
Target Recruit Count
21
Registration Number
NCT00495053
Locations
🇺🇸
CE3, Inc., Branford, Connecticut, United States
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy